LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Lista de Ações・Stryker Corp

Stryker Corp

Fechado

SetorSaúde

300.74 1.73

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

295.06

Máximo

305.82

Indicadores-chave
By Trading Economics
Rendimento	-104M 745M
Vendas	-1.2B 6B
P/E Médio do Setor	34.62 49.888
EPS	2.6
Rendimento de Dividendos	1.13
Margem de lucro	12.375
Funcionários	56,000
EBITDA	-478M 1.2B

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+31.53% upside

Dividendos
By Dow Jones
Rendimento de Dividendos Médio do Setor	1.13% 2.38%
Próximos Ganhos	30 de jul. de 2026
Próxima data de dividendos	31 de jul. de 2026
Próxima data de ex-dividendo	30 de jun. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-11B 115B
Abertura anterior	299.01
Fecho anterior	300.74

Sentimento de Notícias

By Acuity

55%

45%

274 / 344 Ranking em Healthcare

Stryker Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

30 de abr. de 2026, 20:41 UTC

Ganhos

Stryker 1Q Sales, Profit Rise as it Dealt with Cyberattack

12 de mar. de 2026, 21:42 UTC

Notícias Principais

Stryker Says Cyberattack Disruption Is Continuing

11 de mar. de 2026, 19:18 UTC

Grandes Movimentos do Mercado

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

29 de jan. de 2026, 22:05 UTC

Ganhos

Stryker Logs Higher 4Q Profit On Sales Gains

30 de out. de 2025, 20:36 UTC

Ganhos

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

30 de abr. de 2026, 20:06 UTC

Ganhos

Stryker 1Q Organic Net Sales Up 2.4%

30 de abr. de 2026, 20:06 UTC

Ganhos

Stryker Backs FY26 Adj EPS $14.90-Adj EPS $15.10 >SYK

30 de abr. de 2026, 20:05 UTC

Ganhos

Stryker Still Sees FY26 Organic Sales Grwoth 8% to 9.5%

30 de abr. de 2026, 20:05 UTC

Ganhos

Stryker 1Q Adj EPS $2.60 >SYK

30 de abr. de 2026, 20:05 UTC

Ganhos

Stryker 1Q EPS $1.93 >SYK

30 de abr. de 2026, 20:05 UTC

Ganhos

Stryker 1Q Net $745M >SYK

30 de abr. de 2026, 20:05 UTC

Ganhos

Stryker 1Q Sales $6.02B >SYK

30 de abr. de 2026, 20:05 UTC

Ganhos

Stryker 1Q Net $745M >SYK

30 de abr. de 2026, 20:05 UTC

Ganhos

Stryker 1Q Adj EPS $2.60 >SYK

30 de abr. de 2026, 20:05 UTC

Ganhos

Stryker 1Q EPS $1.93 >SYK

30 de abr. de 2026, 20:05 UTC

Ganhos

Stryker 1Q Sales $6B >SYK

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

16 de mar. de 2026, 00:00 UTC

Notícias Principais

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

30 de jan. de 2026, 17:03 UTC

Conversa de Mercado

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29 de jan. de 2026, 21:07 UTC

Ganhos

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29 de jan. de 2026, 21:05 UTC

Ganhos

Stryker 4Q Adj EPS $4.47 >SYK

5 de nov. de 2025, 19:38 UTC

Ganhos

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 de nov. de 2025, 17:00 UTC

Ganhos

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 de out. de 2025, 20:21 UTC

Ganhos

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 de out. de 2025, 20:05 UTC

Ganhos

Stryker 3Q Adj EPS $3.19 >SYK

30 de out. de 2025, 20:05 UTC

Ganhos

Stryker 3Q EPS $2.22 >SYK

30 de out. de 2025, 20:05 UTC

Ganhos

Stryker 3Q Sales $6.1B >SYK

30 de out. de 2025, 20:05 UTC

Ganhos

Stryker 3Q Net $859M >SYK

Comparação entre Pares

Variação de preço

Stryker Corp Previsão

Preço-alvo

By TipRanks

31.53% parte superior

Previsão para 12 meses

Média 388 USD 31.53%

Máximo 450 USD

Mínimo 315 USD

Com base em 22 analistas de Wall Street que oferecem metas de preço de 12 meses para Stryker Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

22 ratings

Comprar

Manter

Vender

Com base em 22 analistas que deram avaliações de ações para Stryker Corp - Dist nos últimos 3 meses.

Sentimento

By Acuity

274 / 344 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.